BCL2 and cancer: Most of the pulmonary tuft cell-like cancers of Cohort-J strongly expressed BCL2 and KIT protein, and the percentages of immunoreactive cells were significantly higher in the tuft cell-like than non-tuft cell-like groups (P < 0.05) (Fig. 2A–C).